The study involved a phase 3 clinical trial where participants received a kidney and stem cell transplant from a closely ...

Hoping to someday stave off immune rejection after xenotransplantation, researchers at New York University's Langone ...

A pioneering study has provided unprecedented insights into the immune response following pig-to-human kidney ...

Sanofi's riliprubart gets FDA orphan drug status for organ transplant rejection, unlocking key development perks.

Discovery of innate immune receptor "brake" Siglec-E offers a novel therapeutic target to prevent organ transplant rejection in mice.

Current treatments to prevent organ transplant rejection focus mainly on suppressing T cells, part of the adaptive immune system. However, the innate immune system -- the body's first line of ...

Download this Forbidden Sign With Gallbladder Line Icon Amputation Internal Organ No Gallbladder Transplant Rejection Symbol Vector Illustration vector illustration now. And search more of iStock's ...

Eledon Pharmaceuticals is poised to revolutionize kidney transplant care with tegoprubart, targeting a $6B market. Read why ELDN stock is a strong buy.

Tech expert Kurt “CyberGuy" Knutsson talks about how the first nonstop beating heart transplant, called zero ischemic time, at Taiwan hospital changes surgery.

Surgeons at NYU Langone Health in New York City had to remove a genetically modified pig kidney from Towana Looney, 53, of Gadsden, Ala., because her body rejected the organ. She's back on dialysis.

Towana Looney lived with the kidney longer than any other transplant patient had tolerated an organ from a genetically modified animal.

The kidney transplant rejection market report provides current treatment practices, emerging drugs, market share of individual therapies, and current and forecasted 7 Major Markets (7MM) kidney ...